MedPath
HSA Approval

Codipront Capsule

SIN13319P

Codipront Capsule

Codipront Capsule

July 30, 2007

RX PHARMA PTE. LTD.

RX PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRX PHARMA PTE. LTD.
Licence HolderRX PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

CAPSULE, EXTENDED RELEASE

ORAL

Medical Information

R05DA20

combinations

Manufacturer Information

RX PHARMA PTE. LTD.

CTS Chemical Industries Ltd

Active Ingredients

Codeine Base ( as Codeine Phosphate Hemihydrate)

30mg

Codeine

PHENYLTOLOXAMINE CITRATE EQV PHENYLTOLOXAMINE BASE

10mg

Phenyltoloxamine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Codipront Capsule - HSA Approval | MedPath